43 research outputs found

    NMR study for electrochemically inserted Na in hard carbon electrode of sodium ion battery

    Get PDF
    The state of sodium inserted in the hard carbon electrode of a sodium ion battery having practical cyclability was investigated using solid state 23Na NMR. The spectra of carbon samples charged (reduced) above 50 mAh g−1 showed clear three components. Two peaks at 9.9 ppm and 5.2 ppm were ascribed to reversible sodium stored between disordered graphene sheets in hard carbon because the shift of the peaks was invariable with changing strength of external magnetic field. One broad signal at about −9 to −16 ppm was assigned to sodium in heterogeneously distributed closed nanopores in hard carbon. Low temperature 23Na static and magic angle spinning NMR spectra didn't split or shift whereas the spectral pattern of 7Li NMR for lithium-inserted hard carbon changes depending on the temperature. This strongly suggests that the exchange of sodium atoms between different sites in hard carbon is slow. These studies show that sodium doesn't form quasi-metallic clusters in closed nanopores of hard carbon although sodium assembles at nanopores while the cell is electrochemically charged

    Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma

    Get PDF
    Background: The Hedgehog (Hh) signalling pathway is overexpressed in pancreatic ductal adenocarcinoma (PDA). Preclinical studies have shown that Hh inhibitors reduce pancreatic cancer stem cells (pCSC), stroma and Hh signalling. Methods: Patients with previously untreated metastatic PDA were treated with gemcitabine and nab-paclitaxel. Vismodegib was added starting on the second cycle. The primary endpoint was progression-free survival (PFS) as compared with historical controls. Tumour biopsies to assess pCSC, stroma and Hh signalling were obtained before treatment and after cycle 1 (gemcitabine and nab-paclitaxel) or after cycle 2 (gemcitabine and nab-paclitaxel plus vismodegib). Results: Seventy-one patients were enrolled. Median PFS and overall survival (OS) were 5.42 months (95% confidence interval [CI]: 4.37–6.97) and 9.79 months (95% CI: 7.85–10.97), respectively. Of the 67 patients evaluable for response, 27 (40%) had a response: 26 (38.8%) partial responses and 1 complete response. In the tumour samples, there were no significant changes in ALDH + pCSC following treatment. Conclusions: Adding vismodegib to chemotherapy did not improve efficacy as compared with historical rates observed with chemotherapy alone in patients with newly diagnosed metastatic pancreatic cancer. This study does not support the further evaluation of Hh inhibitors in this patient population. Trial registration: ClinicalTrials.gov Identifier: NCT01088815

    NaFe0.5Co0.5O2 as high energy and power positive electrode for Na-ion batteries

    No full text
    O3-type NaFeO2 is a promising candidate as positive electrode materials for rechargeable Na batteries. However, its reversible range of sodium extraction is relatively narrow (x = ca. 0.4 in Na1 − xFeO2) because of the irreversible structural change, presumably associated with the iron migration into the adjacent tetrahedral sites in Na layers as we recently reported. Herein, we report that cobalt-substituted NaFeO2 demonstrates excellent electrode performance in a non-aqueous Na cell at room temperature. NaFe0.5Co0.5O2 delivers approximately 160 mAh g−1 of reversible capacity with relatively good capacity retention and excellent rate-capability in a voltage range of 2.5–4.0 V, resulting in reversible formation of Na0.3Fe0.5Co0.5O2. The partial substitution of metal element for Fe in O3-type NaFeO2-based materials is proved to be the important strategy to suppress the irreversible phase transition, and thus improving the reversibility of sodium removal/insertion as the electrode materials. Keywords: Sodium, Intercalation, Na-ion battery, NaFeO2, NaCoO
    corecore